Trial of Early Initiation of CGM-Guided Insulin Therapy in Stage 2 T1D
Condition(s):Type 1 Diabetes; Prediabetic State; Dysglycemia; Autoimmune DiabetesLast Updated:May 9, 2022Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Type 1 Diabetes; Prediabetic State; Dysglycemia; Autoimmune DiabetesLast Updated:May 9, 2022Enrolling by invitation
Condition(s):Gaucher Disease; Fabry DiseaseLast Updated:December 16, 2020Completed
Condition(s):Burn Injury; Chronic PainLast Updated:October 19, 2023Recruiting
Condition(s):Psychotic Disorder; Bipolar Disorder; Depressive DisorderLast Updated:January 25, 2023Completed
Condition(s):Long COVIDLast Updated:March 19, 2024Completed
Condition(s):Infant, Low Birth WeightLast Updated:May 4, 2021Unknown status
Condition(s):Fall Risk Factors; Fall PreventionLast Updated:March 21, 2017Completed
Condition(s):Pneumonia, Pneumocystis Carinii; HIV InfectionsLast Updated:October 1, 2013Completed
Condition(s):HypertensionLast Updated:May 21, 2008Unknown status
Condition(s):Attention-Deficit/Hyperactivity Disorder; Drop-out; Non-adherenceLast Updated:August 27, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.